Novavax (NVAX) Sales of Property, Plant and Equipment (2012 - 2026)

Novavax (NVAX) Sales of Property, Plant and Equipment (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 27,000.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Novavax 1.23 Bn 440.77 Mn 108.82 Mn 39.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 39.80 Mn
Mar 31, 2026 39.80 Mn
Dec 31, 2015 18,000.00
Dec 31, 2015 18,000.00
Sep 30, 2014 27,000.00
Sep 30, 2014 27,000.00
Dec 31, 2013 33,000.00
Dec 31, 2013 33,000.00
Sep 30, 2013 2,000.00
Sep 30, 2013 2,000.00
Jun 30, 2013 30,000.00
Jun 30, 2013 30,000.00
Mar 31, 2013 51,000.00
Mar 31, 2013 51,000.00
Dec 31, 2012 6,000.00
Dec 31, 2012 6,000.00
Sep 30, 2012 151,000.00
Sep 30, 2012 151,000.00